Altered nicotinamide adenine dinucleotide (NADH) fluorescence in dtsz mutant hamsters reflects differences in striatal metabolism between severe and mild dystonia

Journal of Neuroscience Research

Volumn 87, Issue 3, 2009, Pages 776-783

  Hamann, Melanie ^a   Richter, Angelika ^a   Fink, Heidrun ^a   Rex, André ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Animal models; Dyskinesia; In vivo; Laser induced fluorescence; Movement disorder

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; CELL ACTIVITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FLUORESCENCE SPECTROSCOPY; HAMSTER; MALE; NONHUMAN; PAROXYSMAL DYSTONIA; PRIORITY JOURNAL; PROTEIN METABOLISM; STRIATE CORTEX;

ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; CORPUS STRIATUM; CRICETINAE; DYSTONIA; FEMALE; MALE; MESOCRICETUS; NAD; NEURONS; PHYSICAL STIMULATION; SPECTROMETRY, FLUORESCENCE;

EID: 62849119322     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21891     Document Type: Article

References (50)

1. Abbott LF, Nelson SB. 2000. Synaptic plasticity: taming the beast. Nat Neurosci 3(Suppl):1178-1183.
2. Ames A, 3rd. 2000. CNS energy metabolism as related to function. Brain Res Brain Res Rev 34:42-68.
3. Barros LF, Porras OH, Bittner CX. 2005. Why glucose transport in the brain matters for PET. Trends Neurosci 28:117-119.
4. Benecke R, Strumper P, Weiss H. 1992. Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 32:683-686.
5. Brennan AM, Connor JA, Shuttleworth CW. 2006. NAD(P)H fluorescence transients after synaptic activity in brain slices: predominant role of mitochondrial function. J Cereb Blood Flow Metab 26:1389-1406.
6. Carbon M, Su S, Dhawan V, Raymond D, Bressman S, Eidelberg D. 2004. Regional metabolism in primary torsion dystonia: effects of penetrance and genotype. Neurology 62:1384-1390.
7. Dora E, Gyulai L, Kovach AG. 1984. Determinants of brain activation-induced cortical NAD/NADH responses in vivo. Brain Res 299:61-72.
8. Fahn S, Bressman SB, Marsden CD. 1998. Classification of dystonia. Adv Neurol 78:1-10.
9. Gernert M, Richter A, Rundfeldt C, Löscher W. 1998. Quantitative EEG analysis of depth electrode recordings from several brain regions of mutant hamsters with paroxysmal dystonia discloses frequency changes in the basal ganglia. Mov Disord 13:509-521.
10. Gernert M, Richter A, Löscher W. 1999a. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters. Brain Res 821:277-285.
11. Gernert M, Richter A, Löscher W. 1999b. In vivo extracellular electrophysiology of pallidal neurons in dystonic and nondystonic hamsters. J Neurosci Res 57:894-905.
12. Gernert M, Hamann M, Bennay M, Löscher W, Richter A. 2000. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J Neurosci 20:7052-7058.
13. Gernert M, Bennay M, Fedrowitz M, Rehders JH, Richter A. 2002. Altered discharge pattern of basal ganglia output neurons in an animal model of idiopathic dystonia. J Neurosci 22:7244-7253.
14. Hamann M, Richter A. 2004. Striatal increase of extracellular dopamine levels during dystonic episodes in a genetic model of paroxysmal dyskinesia. Neurobiol Dis 16:78-84.
15. Hamann M, Sander SE, Richter A. 2005. Age-dependent alterations of striatal calretinin interneuron density in a genetic animal model of primary paroxysmal dystonia. J Neuropathol Exp Neurol 64:776-781.
16. Harbig K, Chance B, Kovach AG, Reivich M. 1976. In vivo measurement of pyridine nucleotide fluorescence from cat brain cortex. J Appl Physiol 41:480-488.
17. Hevner RE, Liu S, Wong-Riley MT. 1995. A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 65:313-342.
18. Ince C, Goremans JM, Bruining HA. 1992. In vivo NADH fluorescence. Adv Exp Med Biol 317:277-296.
19. Kann O, Kovacs R. 2007. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292:C641-C657.
20. Kann O, Schuchmann S, Buchheim K, Heinemann U. 2003. Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience 119:87-100.
21. Kasischke KA, Vishwasrao HD, Fisher PJ, Zipfel WR, Webb WW. 2004. Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis: Science 305:99-103.
22. Köhling R, Koch UR, Hamann M, Richter A. 2004. Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia. Neurobiol Dis 16:236-245.
23. LaManna JC, Sylvia AL, Martel D, Rosenthal M. 1976. Fluorometric monitoring of the effects of adrenergic agents on oxidative metabolism in intact cerebral cortex. Neuropharmacology 15:17-24.
24. Magistretti PJ, Pellerin L. 1999. Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 354:1155-1163.
25. Mayevsky A. 1984. Brain NADH redox state monitored in vivo by fiber optic surface fluorometry. Brain Res 319:49-68.
26. Morin LP, Wood RI. 2001. A stereotaxic atlas of the golden hamster brain. San Diego: Academic Press. 146 p.
27. Mottin S, Laporte P, Jouvet M, Cespuglio R. 1997. Determination of NADH in the rat brain during sleep-wake states with an optic fiber sensor and time-resolved fluorescence pucedures. Neuroscience 79:683-693.
28. Mottin S, Laporte P, Cespuglio R. 2003. Inhibition of NADH oxidation by chloramphenicol in the freely moving rat measured by picosecond time-resolved emission spectroscopy. J Neurochem 84:633-642.
29. Nardocci N, Fernandez-Alvarez E, Wood NW, Spacy SD, Richter A. 2002. The paroxysmal dyskinesias. In: Guerrini R, Aicardi J, Andermann F, Hallett M, editors. Epilepsy and movement disorders. Cambridge: Cambridge University Press. p 125-139.
30. Nobrega JN, Richter A, Jiwa D, Raymond R, Löscher W. 1998. Regional alterations in neuronal activity in dystonic hamster brain determined by quantitative cytochrome oxidase histochemistry. Neuroscience 83:1215-1223.
31. Raike RS, Jinnah HA, Hess EJ. 2005. Animal models of generalized dystonia, NeuroRx 2:504-512.
32. Rex A, Fink F. 2006a. Applications of laser-induced fluorescence spectroscopy for the determination of NADH in experimental neuroscience. Laser Phys Lett 3:452-459.
33. Rex A, Fink H. 2006b. Effects of 8-OH-DPAT on hippocampal NADH. fluorescence in vivo in anaesthetized rats. J Neurosci Res 83:551-556.
34. Rex A, Pfeifer L, Fink F, Fink H. 1999. Cortical NADH during pharmacological manipulations of the respiratory chain and spreading depression in vivo. J Neurosci Res 57:359-370.
35. Rex A, Pfeifer L, Fink H. 2001. Determination of NADH in frozen at brain sections by laser-induced fluorescence. Biol Chem 382:1727-1732.
36. Richards TL, Pazdernik TL, Levant B. 2007. Clorgyline-induced modification of behavioral sensitization to quinpirole: effects on local cerebral glucose utilizatioin. Brain Res 1160:124-133.
37. Richter A. 2005. The genetically dystonic hamster: an animal model of paroxysmal dystonia. In: LeDoux M, editor. Animal models of movement disorders. San Diego: Elsevier Academic Press. p 459-466.
38. Richter A, Löscher W. 1998. pathology of idiopathic dystonia: findings from genetic animal models. Prog Neurobiol 54:633-677.
39. 3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor system. Mov Disord 13:718-725.
40. 3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor system. Mov Disord 13:718-725.
41. Sander SE, Hamann M, Richter A. 2005. Age-related changes in striatal NOS-immunoreactive interneurons in the dystonic dt(sz) mutant hamster. Neuropathol Appl Neurobiol (in press).
42. Sarzi E, Brown MD, Lebon S, Chretien D, Munnich A, Rotig A, Procaccio V. 2007. A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am J Med Genet A143:33-41.
43. Shapira AHV. 1998. Human complex I defects in neurodegenerative diseases. Biochim Biophys Acta 1364:261-270.
44. Shuttleworth CW, Brennan AM, Connor JA. 2003. NAD(P)H fluorescence imaging of postsynaptic neuronal activation in murine hippocampal slices. J Neurosci 23:3196-3208.
45. Simon DK, Friedman J, Breakefield XO, Jankovic J, Brin MF, Provias J, Bressman SB, Charness ME, Tarsy D, Johns DR, Tarnopolsky MA. 2003. A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics 4:199-205.
46. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916.
47. Tepper JM, Bolam JP. 2004. Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 14:685-692.
48. Vitek JL. 2002. Pathophysiology of dystonia: a neuronal model. Mov Disord 17 Suppl 3:S49-S62.
49. Vitek JL, Giroux M. 2000. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann Neurol 47(Suppl 1):S131-S140.
50. Wong-Riley MT. 1989. Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94-101.